Zhang Man, Li Ke, Kou Junhao, Lu Guozhi, Qiu Ling, Yang Chunzhao, Liu Yongchun, Xue Qi, Yang Peng
Department of General Surgery Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine Southern Medical University Guangdong 510315 China.
Xi'an Key Laboratory for Prevention and Treatment of Common Aging Diseases Translational and Research Centre for Prevention and Therapy of Chronic Disease Institute of Basic and Translational Medicine Xi'an Medical University Xi'an 710021 China.
Small Sci. 2024 Sep 23;4(11):2400323. doi: 10.1002/smsc.202400323. eCollection 2024 Nov.
Colorectal cancer (CRC) has a postoperative recurrence rate of up to 50%. Local treatment at the surgical site offers a new strategy to prevent recurrence, minimizing systemic side effects. However, these treatments often face issues like poor stability, insufficient targeting, and significant local side effects. Research shows glucose starvation can induce disulfidptosis, a novel cell death pathway, in CRC cells, suitable for precise intervention in residual tumor cells postsurgery. This study develops a biocompatible 2D therapeutic platform using amyloid-like protein nanofilm technology for precise local synergistic intervention in disulfidptosis and photodynamic therapy (PDT) after CRC surgery. The nanofilm boasts excellent drug-loading capacity, enzyme activity retention, ultrathin dimensions, wet adhesion, and biocompatibility. A model simulating incomplete tumor resection post-CRC surgery shows that the GCI@nanofilm effectively inhibits recurrence through an enzyme-catalyzed cascade reaction inducing disulfidptosis and synergizing with PDT. In summary, GCI@nanofilm overcomes multiple challenges in local postsurgical intervention, providing a foundation for precise and efficient treatment of residual tumors.
结直肠癌(CRC)术后复发率高达50%。手术部位的局部治疗为预防复发提供了一种新策略,可将全身副作用降至最低。然而,这些治疗方法往往面临稳定性差、靶向性不足和严重局部副作用等问题。研究表明,葡萄糖饥饿可诱导CRC细胞发生一种新的细胞死亡途径——二硫键介导的细胞焦亡,适用于术后对残留肿瘤细胞进行精确干预。本研究利用类淀粉样蛋白纳米膜技术开发了一种生物相容性二维治疗平台,用于CRC术后对二硫键介导的细胞焦亡和光动力疗法(PDT)进行精确的局部协同干预。该纳米膜具有优异的载药能力、酶活性保留、超薄尺寸、湿粘附性和生物相容性。一个模拟CRC术后肿瘤切除不完全的模型表明,GCI@纳米膜通过酶催化级联反应诱导二硫键介导的细胞焦亡并与PDT协同作用,有效抑制复发。总之,GCI@纳米膜克服了术后局部干预中的多重挑战,为精确、高效治疗残留肿瘤奠定了基础。